Phibro Animal Health | PAHC - Interest Expense On Debt


Phibro Animal Health reported $11.91M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Align Technology USD 9.96M 3.02M Jun/2026
ANI Pharmaceuticals USD 3.06M 580K Sep/2026
Aurora Cannabis CAD 464K 234K Jun/2026
Bristol-Myers Squibb USD 403M 4M Sep/2026
Canopy Growth CAD 12.68M 364K Jun/2026
Corcept Therapeutics USD 1.03B 145.32M Sep/2026
Eli Lilly USD 316M 201.3M Sep/2026
Henry Schein USD 42M 1000K Sep/2026
Idexx Laboratories USD 7.46M 2.72M Sep/2026
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Merck USD 525M 46M Jun/2026
Nektar Therapeutics USD 7.94M 1.83M Mar/2026
Pacira USD 112.4M 108.78M Sep/2026
Phibro Animal Health USD 11.91M 191K Dec/2025
Prestige Brands USD 13.94M 2.52M Jun/2026
Supernus Pharmaceuticals USD 718K 1.6M Sep/2026
Zoetis USD 62M 1000K Sep/2026